| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |